Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BioInvent
Biotech
Exelixis signs on $25M to check out BioInvent's antibody library
Exelixis will pay $25 million upfront for the right to check out three drug targets from BioInvent's library.
Gabrielle Masson
Jun 16, 2022 11:26am
Chutes & Ladders—Five Prime’s COO to succeed founder as CEO
Oct 27, 2017 4:35am
BioInvent CEO resigns in shift toward scientific leadership
Oct 25, 2017 8:06am
EuroBiotech: More Articles of Note
Jul 13, 2017 6:15am
After trial disaster, BioInvent bounces back with Pfizer deal
Dec 21, 2016 4:25am
EuroBiotech Report: Woodford’s loss, BioInvent’s major failure, Pulmagen wants a partner, Amcure’s raise, and Bayer/Versant laun
Dec 15, 2016 2:45am
